The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of luspatercept with or without hydroxyurea for the treatment of patients with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis or unclassifiable with ring sideroblasts.
 
Abhishek Avinash Mangaonkar
Research Funding - BMS (Inst)
 
Cecilia Ysabel Arana Yi
No Relationships to Disclose
 
Hemant S. Murthy
Research Funding - crispr therapeutics (Inst)
 
Talha Badar
No Relationships to Disclose
 
James M. Foran
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Novartis; SERVIER; Syros Pharmaceuticals; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Actinium Pharmaceuticals (Inst); Aptose Biosciences (Inst); H3 Biomedicine (Inst); Kura Oncology (Inst); Sellas Life Sciences (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Susan Michelle Geyer
No Relationships to Disclose
 
Kristen Beth McCullough
No Relationships to Disclose
 
Erinayo S Baba Lola
No Relationships to Disclose
 
Jean Hanson
No Relationships to Disclose
 
Aref Al-Kali
Research Funding - Ambit BioSciences (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); H3 Biomedicine (Inst); MedImmune (Inst); Novartis (Inst); Onconova Therapeutics (Inst)
 
Hassan B. Alkhateeb
No Relationships to Disclose
 
Mithun Vinod Shah
Research Funding - Archer
 
Kebede Begna
No Relationships to Disclose
 
Michelle A. Elliott
No Relationships to Disclose
 
Naseema Gangat
No Relationships to Disclose
 
Mark Robert Litzow
Consulting or Advisory Role - Jazz Pharmaceuticals; Omeros
Research Funding - Abbvie; Abbvie/Genentech; Actinium Pharmaceuticals; Amgen; Astellas Pharma; Pluristem Therapeutics; Tolero Pharmaceuticals
Other Relationship - Biosight
 
Alexandra P. Wolanskyj-Spinner
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Ayalew Tefferi
No Relationships to Disclose
 
Mrinal Patnaik
Consulting or Advisory Role - Stemline Therapeutics (Inst)
Research Funding - Kura Oncology (Inst)